Difference between revisions of "Template:SPCaripiprazoleLA"

Revision as of 12:08, 20 February 2025

More information you'll find in the summary of product characteristics (SPC) of aripiprazole depot injection. ^[1]
Aripiprazol Abilify Maintena is a prolonged release suspension for injection and is available in 400mg and 960mg preparations.

Revision as of 11:54, 17 March 2015 (view source) Walter (talk \| contribs) ← Older edit		Revision as of 12:08, 20 February 2025 (view source) Casper (talk \| contribs) Newer edit →
Line 1:		Line 1:
−	* More information you'll find in the summary of product characteristics (SPC) of aripiprazole depot injection. <ref>~~http~~://www.ema.europa.eu/~~docs~~/~~en_GB/document_library/EPAR_-_Product_Information~~/human/~~002755~~/~~WC500156111.pdf~~ SPC of the European Medicines Agency on aripiprazole depot</ref>	+	* More information you'll find in the summary of product characteristics (SPC) of aripiprazole depot injection. <ref>https://www.ema.europa.eu/en/medicines/human/EPAR/abilify-maintena SPC of the European Medicines Agency on aripiprazole depot</ref>
		+	* Aripiprazol Abilify Maintena is a prolonged release suspension for injection and is available in 400mg and 960mg preparations.